Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment

J Psychiatr Res. 2003 May-Jun;37(3):261-2. doi: 10.1016/s0022-3956(02)00102-4.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antidepressive Agents / therapeutic use*
  • Citalopram / administration & dosage
  • Citalopram / pharmacology*
  • Depressive Disorder / drug therapy*
  • Humans
  • Monoamine Oxidase / metabolism
  • Morpholines / administration & dosage
  • Morpholines / pharmacology*
  • Prolactin / metabolism*
  • Prospective Studies
  • Reboxetine
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Time Factors

Substances

  • Antidepressive Agents
  • Morpholines
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Prolactin
  • Reboxetine
  • Monoamine Oxidase